SBC Medical Group Holdings Inc SEC filings SBCWW
SBC Medical Group Holdings Inc has 232 filings in SEC EDGAR's recent list, going back to Jun 14, 2022. Its latest annual report, Form ARS, was filed on May 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Listing notice, Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
Jul 14, 2026 | Jul 8, 2026 |
| ARS | Annual report to shareholders | May 28, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | May 28, 2026 | — |
| DEF 14A | Proxy statement | May 28, 2026 | May 28, 2026 |
| 8-K |
Current report
Officer or director change
|
May 20, 2026 | May 14, 2026 |
| PRE 14A | Preliminary proxy statement | May 15, 2026 | May 15, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 14, 2026 | May 14, 2026 |
| 10-K/A | Amended annual report | Apr 30, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Apr 29, 2026 | Apr 28, 2026 |
| 4 | Insider transaction | Apr 23, 2026 | Apr 21, 2026 |
| 8-K |
Current report
Material agreement
|
Apr 23, 2026 | Apr 19, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Apr 21, 2026 | — |
| 424B7 | Filing | Apr 20, 2026 | — |
| 424B7 | Filing | Apr 17, 2026 | — |
| 10-K | Annual report | Mar 27, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Mar 27, 2026 | Mar 27, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 13, 2026 | — |
| 4 | Insider transaction | Mar 10, 2026 | Mar 6, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 10, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 5, 2026 | Jan 5, 2026 |
| 424B3 | Prospectus | Jan 5, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 31, 2025 | Dec 31, 2025 |
| EFFECT | Filing | Dec 30, 2025 | — |
| CORRESP | Letter to the SEC | Dec 29, 2025 | — |
| S-3 | Shelf registration | Dec 29, 2025 | — |
| 8-K |
Current report
Other events
|
Dec 15, 2025 | Dec 13, 2025 |
| 424B3 | Prospectus | Nov 17, 2025 | — |
| DRS | Filing | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| 8-K |
Current report
Other events
|
Nov 13, 2025 | Nov 13, 2025 |
| 424B3 | Prospectus | Aug 15, 2025 | — |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 424B3 | Prospectus | Aug 6, 2025 | — |
| EFFECT | Filing | Aug 4, 2025 | — |
| POS AM | Filing | Jul 22, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 17, 2025 | Jul 17, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 30, 2025 | Jun 27, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 18, 2025 | Jun 13, 2025 |
| DEF 14A | Proxy statement | May 28, 2025 | May 28, 2025 |
| 424B3 | Prospectus | May 19, 2025 | — |
| PRE 14A | Preliminary proxy statement | May 15, 2025 | May 15, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2025 | May 15, 2025 |
| 10-K/A | Amended annual report | May 9, 2025 | Dec 31, 2024 |
| 10-K/A | Amended annual report | Apr 30, 2025 | Dec 31, 2024 |
| 3 | Initial insider ownership | Apr 18, 2025 | Apr 10, 2025 |
| 3/A | Filing | Apr 9, 2025 | Sep 17, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2025 | Mar 27, 2025 |
| 424B3 | Prospectus | Apr 1, 2025 | — |
| POS EX | Filing | Apr 1, 2025 | — |
| 10-K | Annual report | Mar 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2025 | Mar 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 18, 2025 | Feb 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 20, 2024 | Dec 20, 2024 |
| 424B3 | Prospectus | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 424B3 | Prospectus | Oct 21, 2024 | — |
| EFFECT | Filing | Oct 18, 2024 | — |
| CORRESP | Letter to the SEC | Oct 16, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 15, 2024 | — |
| S-1 | Registration statement | Oct 8, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Oct 1, 2024 | — |
| 4 | Insider transaction | Sep 30, 2024 | Sep 30, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Sep 24, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Sep 23, 2024 | — |
| SC 13D | Ownership over 5% (active) | Sep 23, 2024 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Sep 20, 2024 | Sep 17, 2024 |
| 4 | Insider transaction | Sep 19, 2024 | Sep 17, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Sep 19, 2024 | — |
| 25-NSE | Delisting notice | Sep 18, 2024 | — |
| 4 | Insider transaction | Sep 17, 2024 | Sep 17, 2024 |
| 3 | Initial insider ownership | Sep 17, 2024 | Sep 17, 2024 |
| 3 | Initial insider ownership | Sep 17, 2024 | Sep 17, 2024 |
| 3 | Initial insider ownership | Sep 17, 2024 | Sep 17, 2024 |
| 3 | Initial insider ownership | Sep 17, 2024 | Sep 17, 2024 |
| 3 | Initial insider ownership | Sep 17, 2024 | Sep 17, 2024 |
| 3 | Initial insider ownership | Sep 17, 2024 | Sep 17, 2024 |
| 3 | Initial insider ownership | Sep 17, 2024 | Sep 17, 2024 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Aug 29, 2024 | Aug 23, 2024 |
| 4 | Insider transaction | Aug 23, 2024 | Aug 21, 2024 |
| DEFA14A | Additional proxy material | Aug 23, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 23, 2024 | Aug 22, 2024 |
| 4 | Insider transaction | Aug 20, 2024 | Aug 19, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Aug 20, 2024 | — |
| 10-Q | Quarterly report | Aug 16, 2024 | Jun 30, 2024 |
| NT 10-Q | Filing | Aug 14, 2024 | Jun 30, 2024 |
| DEFM14A | Proxy statement | Aug 12, 2024 | — |
| DEFA14A | Additional proxy material | Aug 12, 2024 | — |
| 8-K |
Current report
Material agreement
|
Aug 12, 2024 | Aug 8, 2024 |
| UPLOAD | Letter from the SEC | Aug 9, 2024 | — |
| CORRESP | Letter to the SEC | Aug 7, 2024 | — |
| PRER14A | Proxy statement | Aug 7, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 6, 2024 | — |
| 4 | Insider transaction | Aug 2, 2024 | Jul 31, 2024 |
| PRER14A | Proxy statement | Aug 1, 2024 | — |
| CORRESP | Letter to the SEC | Jul 31, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jul 26, 2024 | — |
| 4 | Insider transaction | Jul 26, 2024 | Jul 24, 2024 |
| 4 | Insider transaction | Jul 19, 2024 | Jul 17, 2024 |
| UPLOAD | Letter from the SEC | Jul 19, 2024 | — |
| 4 | Insider transaction | Jul 16, 2024 | Jul 12, 2024 |
| 4 | Insider transaction | Jul 11, 2024 | Jul 9, 2024 |
| PRER14A | Proxy statement | Jul 10, 2024 | — |
| CORRESP | Letter to the SEC | Jul 9, 2024 | — |
| 4 | Insider transaction | Jul 5, 2024 | Jul 2, 2024 |
| 4 | Insider transaction | Jul 1, 2024 | Jun 27, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jun 28, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 21, 2024 | — |
| PRER14A | Proxy statement | Jun 17, 2024 | — |
| CORRESP | Letter to the SEC | Jun 14, 2024 | — |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | May 31, 2024 |
| 4 | Insider transaction | May 28, 2024 | May 23, 2024 |
| UPLOAD | Letter from the SEC | May 24, 2024 | — |
| 4 | Insider transaction | May 20, 2024 | May 16, 2024 |
| 10-Q | Quarterly report | May 20, 2024 | Mar 31, 2024 |
| 4 | Insider transaction | May 15, 2024 | May 13, 2024 |
| NT 10-Q | Filing | May 15, 2024 | Mar 31, 2024 |
| 4 | Insider transaction | May 10, 2024 | May 8, 2024 |
| 8-K |
Current report
Listing notice
|
May 8, 2024 | May 6, 2024 |
| CORRESP | Letter to the SEC | May 7, 2024 | — |
| PRER14A | Proxy statement | May 7, 2024 | — |
| 4 | Insider transaction | May 2, 2024 | Apr 30, 2024 |
| 4 | Insider transaction | Apr 25, 2024 | Apr 23, 2024 |
| DEFA14A | Additional proxy material | Apr 23, 2024 | — |
| 8-K |
Current report
Material agreement
|
Apr 23, 2024 | Apr 22, 2024 |
| 4 | Insider transaction | Apr 11, 2024 | Apr 9, 2024 |
| 4 | Insider transaction | Apr 8, 2024 | Apr 4, 2024 |
| 8-K |
Current report
Listing notice
|
Apr 4, 2024 | Apr 2, 2024 |
| 4 | Insider transaction | Apr 3, 2024 | Apr 1, 2024 |
| 4 | Insider transaction | Mar 28, 2024 | Mar 27, 2024 |
| 4 | Insider transaction | Mar 26, 2024 | Mar 22, 2024 |
| 4 | Insider transaction | Mar 21, 2024 | Mar 19, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 21, 2024 | — |
| 10-K | Annual report | Mar 19, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Mar 13, 2024 | Mar 11, 2024 |
| 4 | Insider transaction | Mar 8, 2024 | Mar 6, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| DEFA14A | Additional proxy material | Mar 1, 2024 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Mar 1, 2024 | Feb 27, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 1, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Feb 29, 2024 | — |
| 4 | Insider transaction | Feb 29, 2024 | Feb 27, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| UPLOAD | Letter from the SEC | Feb 22, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 22, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| 4 | Insider transaction | Feb 13, 2024 | Feb 9, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 8, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
Feb 8, 2024 | Feb 5, 2024 |
| 3 | Initial insider ownership | Feb 6, 2024 | Jan 26, 2024 |
| SC 13D | Ownership over 5% (active) | Feb 6, 2024 | — |
| DEF 14A | Proxy statement | Jan 23, 2024 | Jan 23, 2024 |
| UPLOAD | Letter from the SEC | Jan 22, 2024 | — |
| PRER14A | Proxy statement | Jan 22, 2024 | — |
| CORRESP | Letter to the SEC | Jan 19, 2024 | — |
| DEFA14A | Additional proxy material | Jan 18, 2024 | — |
| 8-K |
Current report
Material agreement
|
Jan 18, 2024 | Jan 11, 2024 |
| PRER14A | Filing | Jan 11, 2024 | — |
| PRE 14A | Preliminary proxy statement | Dec 29, 2023 | Dec 29, 2023 |
| DEFA14A | Additional proxy material | Dec 29, 2023 | — |
| 8-K |
Current report
Material agreement
|
Dec 29, 2023 | Dec 28, 2023 |
| UPLOAD | Letter from the SEC | Dec 7, 2023 | — |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| PREM14A | Proxy statement | Nov 9, 2023 | Nov 8, 2023 |
| DEFA14A | Additional proxy material | Oct 26, 2023 | — |
| 8-K |
Current report
Material agreement
|
Oct 26, 2023 | Oct 26, 2023 |
| DEFA14A | Additional proxy material | Sep 11, 2023 | — |
| 8-K |
Current report
Material agreement
|
Sep 11, 2023 | Sep 8, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| DEFA14A | Additional proxy material | Jun 22, 2023 | — |
| 8-K |
Current report
Material agreement
|
Jun 22, 2023 | Jun 21, 2023 |
| DEFA14A | Additional proxy material | Jun 16, 2023 | — |
| 8-K |
Current report
Material agreement
|
Jun 16, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 2, 2023 | May 26, 2023 |
| DEFA14A | Additional proxy material | Jun 2, 2023 | — |
| DEFA14A | Additional proxy material | May 19, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
May 19, 2023 | May 18, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| SC 13G | Ownership over 5% (passive) | May 10, 2023 | — |
| DEFA14A | Additional proxy material | May 9, 2023 | — |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
May 9, 2023 | May 4, 2023 |
| DEFA14A | Additional proxy material | May 5, 2023 | — |
| DEFA14A | Additional proxy material | May 4, 2023 | — |
| DEFA14A | Additional proxy material | May 4, 2023 | — |
| 8-K |
Current report
Material agreement
|
May 4, 2023 | May 3, 2023 |
| DEFA14A | Additional proxy material | May 1, 2023 | — |
| 8-K |
Current report
Material agreement
|
May 1, 2023 | Apr 26, 2023 |
| DEF 14A | Proxy statement | Apr 24, 2023 | Apr 24, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 7, 2023 | Apr 7, 2023 |
| 10-K | Annual report | Mar 9, 2023 | Dec 31, 2022 |
| 4 | Insider transaction | Mar 8, 2023 | Aug 9, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
- Listed as
- SBC (Nasdaq), SBCWW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Irvine, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1930313
- Former names
- Pono Capital Two, Inc. (until Aug 29, 2024)
Other Services-Offices & Clinics of Doctors of Medicine companies
- Hims & Hers Health, Inc. HIMS
- Teladoc Health, Inc. TDOC
- Starling Oncology, Inc. STLN
- Auna S.A. AUNA
- Airsculpt Technologies, Inc. AIRS
- LifeMD, Inc. LFMD
- Westin Acquisition Corp WSTN
- Basel Medical Group Ltd BMGL
All 12 Services-Offices & Clinics of Doctors of Medicine companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.